To elucidate changes in the tumor microenvironment during ovarian cancer progression, we investigated ECM structure, percentages of fibroblasts, epithelial cancer cells, and immune cells as well as the enrichment of cancer- and stroma-associated CD8+ T cells in longitudinally collected HGSOC samples. This evidence concerns the gene CD8A and ovarian carcinoma.